Five monoclonal antibodies (J14, J9, Q5, K16, S16), directed to three distinct antigenic sites (A-1, A-2, B-1) on the haemagglutinin–esterase glycoprotein of influenza C virus, were analysed for their ability to inhibit the receptor-destroying enzyme (RDE) activity of the virus, utilizing various assay systems. The ability of influenza C virus to destroy the receptors on chicken erythrocytes was inhibited efficiently by the antibodies to site A-1 (J14, J9, Q5) but not by those to site A-2 (K16) and site B-1 (S16). Of the three antibodies to site A-1, J14 showed the highest inhibitory activity. Antibodies to sites A-1 and A-2 inhibited the ability of RDE to inactivate the haemagglutination inhibition activity of rat serum inhibitors, but the highest activity was observed again with J14. Thus the RDE site of influenza C virus may be located closest to the epitope recognized by J14. The removal of O-acetyl groups from either 9-O-acetyl-N-acetylneuraminic acid or p-nitrophenylacetate, caused by the viral RDE, was not prevented at all by any of the monoclonal antibodies tested. Furthermore, none of several polyclonal antiviral sera prepared in different animal species was able to block the hydrolysis of these small substrates, raising the possibility that the catalytic site of influenza C viral RDE is antigenically silent.
HerrlerG.,
GeyerR.,
MüllerH.-P.,
StirmS.,
KlenkH.-D.1985a; Rat α1-macroglobulin inhibits hemagglutination by influenza C virus. Virus Research 2:183–192
HerrlerG.,
RottR.,
KlenkH.-D.,
MüllerH.-P.,
ShuklaA. K.,
SchauerR.1985b; The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO Journal 4:1503–1506
HerrlerG.,
DürkopI.,
BechtH.,
KlenkH.-D.1988; The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. Journal of General Virology 69:839–846
HongoS.,
SugawaraK.,
HommaM.,
NakamuraK.1986; The functions of oligosaccharide chains associated with influenza C viral glycoproteins. II. The role of carbohydrates in the antigenic properties of influenza C viral glycoproteins. Archives of Virology 89:189–201
KitameF.,
NakamuraK.,
SaitoA.,
SinoharaH.,
HommaM.1985; Isolation and characterization of influenza C virus inhibitor in rat serum. Virus Research 3:231–244
NakadaS.,
CreagerR. S.,
KrystalM.,
AaronsonR. P.,
PaleseP.1984; Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins. Journal of Virology 50:118–124
StykB.1963; Effect of some inhibitor-destroying substances on the nonspecific inhibitor of C influenza virus present in normal rat serum. Ada virologica 7:88–89
SugawaraK.,
KitameF.,
HommaM.,
NakamuraK.1985; An assay for the receptor-destroying activity of influenza C virus. Microbiology and Immunology 29:1207–1217
SugawaraK.,
NishimuraH.,
KitameF.,
NakamuraK.1986; Antigenic variation among human strains of influenza C virus detected with monoclonal antibodies to gp88 glycoprotein. Virus Research 6:27–32
SugawaraK.,
KitameF.,
NishimuraH.,
NakamuraK.1988; Operational and topological analysis of antigenic sites on influenza C virus glycoprotein and their dependence on glycosylation. Journal of General Virology 69:537–547